Meng-Chao Liu (Mengchao Liu)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Peritoneal Dialysis

Chronic Kidney Disease

Top Venues

Journal of diabetes research

This page only lists publications with an associated author ORCID identifier.

Publications

Lei Tian, Mengdi Wang, Meng-Chao Liu, Yanyu Pang, Jingwen Zhao, Bingjie Zheng, Yutong Wang, Wenjing Zhao
Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review and meta-analysis. Renal failure 46 (1) (2024)
Lei Tian, Mengdi Wang, Meng-Chao Liu, Yanyu Pang, Jingwen Zhao, Bingjie Zheng, Yutong Wang, Wenjing Zhao
Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review and meta-analysis. Renal failure 46 (1) (2024)
Lei Tian, Mengdi Wang, Meng-Chao Liu, Yanyu Pang, Jingwen Zhao, Bingjie Zheng, Yutong Wang, Wenjing Zhao
Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review and meta-analysis. Renal failure 46 (1) (2024)
Lei Tian, Mengdi Wang, Meng-Chao Liu, Yanyu Pang, Jingwen Zhao, Bingjie Zheng, Yutong Wang, Wenjing Zhao
Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review and meta-analysis. Renal failure 46 (1) (2024)
Lei Tian, Mengdi Wang, Meng-Chao Liu, Yanyu Pang, Jingwen Zhao, Bingjie Zheng, Yutong Wang, Wenjing Zhao
Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review and meta-analysis. Renal failure 46 (1) (2024)
Lei Tian, Mengdi Wang, Meng-Chao Liu, Yanyu Pang, Jingwen Zhao, Bingjie Zheng, Yutong Wang, Wenjing Zhao
Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review and meta-analysis. Renal failure 46 (1) (2024)
Meng-Chao Liu, Wen-Quan Niu, Yue-Fen Wang, Yuan Meng, Gui-Min Zheng, Zhen Cai, Cun Shen, Xiang-Gang Zhu, Meng-di Wang, Jia-Lin Li, Wen-Jing Zhao, Yao Xian Wang
Coagulation Function and Type 2 Diabetic Kidney Disease: A Real-World Observational Study. Journal of diabetes research 2023 (2023)